Literature DB >> 15229352

Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models.

Mark M Huycke1, H Rex Gaskins.   

Abstract

The potential role for commensal bacteria in colorectal carcinogenesis is explored in this review. Most colorectal cancers (CRCs) occur sporadically and arise from the gradual accumulation of mutations in genes regulating cell growth and DNA repair. Genetic mutations followed by clonal selection result in the transformation of normal cells into malignant derivatives. Numerous toxicological effects of colonic bacteria have been reported. However, those recognized as damaging epithelial cell DNA are most easily reconciled with the currently understood genetic basis for sporadic CRC. Thus, we focus on mechanisms by which particular commensal bacteria may convert dietary procarcinogens into DNA damaging agents (e.g., ethanol and heterocyclic amines) or directly generate carcinogens (e.g., fecapentaenes). Although these and other metabolic activities have yet to be linked directly to sporadic CRC, several lines of investigation are reviewed to highlight difficulties and progress in the area. Particular focus is given to commensal bacteria that alter the epithelial redox environment, such as production of oxygen radicals by Enterococcus faecalis or production of hydrogen sulfide by sulfate-reducing bacteria (SRB). Super-oxide-producing E. faecalis has conclusively been shown to cause colonic epithelial cell DNA damage. Though SRB-derived hydrogen sulfide (H(2)S) has not been reported thus far to induce DNA damage or function as a carcinogen, recent data demonstrate that this reductant activates molecular pathways implicated in CRC. These observations combined with evidence that SRB carriage may be genetically encoded evoke a working model that incorporates multifactorial gene-environment interactions that appear to underlie the development of sporadic CRC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229352     DOI: 10.1177/153537020422900702

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  78 in total

Review 1.  Techniques used to characterize the gut microbiota: a guide for the clinician.

Authors:  Marianne H Fraher; Paul W O'Toole; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

2.  Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

Authors:  Nina Sanapareddy; Ryan M Legge; Biljana Jovov; Amber McCoy; Lauren Burcal; Felix Araujo-Perez; Thomas A Randall; Joseph Galanko; Andrew Benson; Robert S Sandler; John F Rawls; Zaid Abdo; Anthony A Fodor; Temitope O Keku
Journal:  ISME J       Date:  2012-05-24       Impact factor: 10.302

Review 3.  Redox biology of the intestine.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Free Radic Res       Date:  2011-09-05

Review 4.  Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.

Authors:  Volker Mai; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 5.  Emerging roles of the microbiome in cancer.

Authors:  Scott J Bultman
Journal:  Carcinogenesis       Date:  2013-12-03       Impact factor: 4.944

Review 6.  Eating for two: how metabolism establishes interspecies interactions in the gut.

Authors:  Michael A Fischbach; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

7.  New horizons for the infectious diseases specialist: how gut microflora promote health and disease.

Authors:  Shervin Rabizadeh; Cynthia Sears
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 8.  The human gut mobile metagenome: a metazoan perspective.

Authors:  Brian V Jones
Journal:  Gut Microbes       Date:  2010 Nov-Dec

Review 9.  Iron, microbiota and colorectal cancer.

Authors:  Oliver Ng
Journal:  Wien Med Wochenschr       Date:  2016-08-30

10.  Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population.

Authors:  Bartosz Mucha; Jacek Kabzinski; Adam Dziki; Karolina Przybylowska-Sygut; Andrzej Sygut; Ireneusz Majsterek; Lukasz Dziki
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.